Latest Insights - page 41 | BiopharmaTrend

Tempus Announces National Launch of AI-Powered Personal Health Assistant

Tempus AI, Inc. (NASDAQ: TEM) has launched olivia, an AI-enabled app designed to help patients organize and manage their health data while navigating the complexities of modern healthcare.

Continue ›››

Study: Trust in Scientists Post-Pandemic Remains High, but Public Wants More Engagement

Led by researchers from Harvard University, ETH Zurich, and the University of Zurich, a recent international study sheds light on public perceptions of scientists and their role in society. This …

Continue ›››

Mayo Clinic Partners with Microsoft and Cerebras on Radiology and Genomics Foundation Models

Mayo Clinic has announced collaborations with Microsoft Research and Cerebras Systems to explore the potential of generative artificial intelligence (AI) in patient care, diagnostics, and treatment planning. These projects, introduced …

Continue ›››

Longevity Company Rubedo Announces Phase 1 Trials for GPX4 Modulator Targeting Aging Cells and Surrounding Tissues

Rubedo Life Sciences has unveiled its clinical development plans for RLS-1496, a first-in-class GPX4 modulator, during the 12th Annual Dermatology Summit, held in conjunction with the J.P. Morgan Healthcare Conference …

Continue ›››

Swiss Researchers Advance Spatial Proteomics with AI-Powered Virtual Tissue Foundation Model

Researchers from École Polytechnique Fédérale de Lausanne (EPFL) and ETH Zurich, in collaboration with the University Hospital Zurich and the University of Zurich, have introduced VirTues (Virtual Tissues), a foundation model …

Continue ›››

Baker Lab: Neutralizing Snake Venom with AI-Designed Miniproteins

Researchers from the Baker Lab at the University of Washington, in collaboration with the Digital Biotechnology Lab at the Technical University of Denmark (DTU) and other institutions, have developed AI-designed …

Continue ›››

Recursion and Faro Health Partner to Reimagine Clinical Trial Design with AI

Faro Health has partnered with Recursion to streamline clinical protocol design using Faro's AI-driven platform.

Continue ›››

Servier, Google Cloud Extend Partnership to Accelerate Drug Development with AI

Servier, an international pharmaceutical group, and Google Cloud have announced a five-year extension of their collaboration to integrate AI technologies across Servier's R&D, production, and distribution activities. This partnership aims …

Continue ›››

Lupa Raises $4M to Modernize Veterinary Care with AI

Lupa, a London-based startup developing an AI-powered veterinary operating system, has raised $4 million in seed funding from investors including firstminute capital, 2100 Ventures, and Exor Ventures. Other investors include top …

Continue ›››

Proscia Grows with 2.4 Million Patients Diagnosed via AI Pathology Platform

Proscia, a company specializing in AI-enabled pathology solutions, reported significant growth in 2024, driven by an increasing demand for enterprise pathology platforms.

Continue ›››

AI-Driven Analysis Optimizes Clinical Strategy for A28’s Liver Cancer Peptide Therapy

A28 Therapeutics, a clinical-stage biopharmaceutical company, and GATC Health Corp, a developer of AI-driven drug discovery tools, have announced the completion of an AI-based analysis of A28’s lead drug candidate, …

Continue ›››

Umoja Secures $100M For In Vivo CAR-T Therapies

Umoja Biopharma has secured $100 million in an oversubscribed Series C funding round. Based in Seattle, Washington, and founded in 2019, Umoja focuses on developing technologies to expand the accessibility …

Continue ›››